FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052606277> ?p ?o ?g. }

• W2052606277 endingPage "653" @default.
• W2052606277 startingPage "641" @default.
• W2052606277 abstract "Antigen-induced activation of resting T cells induces the synthesis of interleukin-2 (IL-2), as well as the expression of specific cell surface high-affinity receptors for this lymphokine. There are at least two forms of the cellular receptors for IL-2, one with a very high affinity and the other with a lower affinity. We have identified two IL-2-binding peptides, a 55-kD peptide reactive with the anti-Tac monoclonal antibody and a 75-kD non-Tac IL-2-binding peptide. Cell lines bearing either the p55 (Tac) or the p75 peptide alone manifested low- to intermediate-affinity IL-2 binding, whereas cell lines bearing both peptides manifested high- and low-affinity receptors. Fusion of cell membranes from low-affinity IL-2-binding cells bearing the Tac peptide alone with membranes from a cell line bearing the p75 peptide alone generated hybrid membranes bearing high-affinity receptors. We propose a multichain model for the high-affinity IL-2-receptor in which both the p55 Tac and the p75 IL-2-binding peptides are associated in a receptor complex. An additional 90–100-kD peptide may also participate in the multi-subunit high-affinity form of the IL-2-receptor. The p75 peptide is the receptor for IL-2 on large granular lymphocytes and is sufficient for the IL-2 activation of these cells. In contrast to resting T cells, the activated T cells in certain neoplasias of mononuclear cells, select autoimmune disorders and in organ allograft rejections express the Tac antigen. Specifically, human T-cell lymphotrophic virus Type I (HTLV-I)-associated adult T-cell leukemia cells constitutively express large numbers of IL-2 Tac receptors. A 42-kD tat protein encoded predominantly by the pX region of HTLV-I may play a role in directly or indirectly increasing the transcription of the 55-kD Tac IL-2-receptor gene. To exploit the fact that IL-2-receptors are present on abnormally activated T cells but not on normal resting cells, clinical trials have been initiated involving patients with neoplastic or autoimmune disorders as well as those receiving organ allografts. These patients are being treated with unmodified anti-Tac, with anti-Tac conjugated to truncated Pseudomonas toxin, with isotopic (212Bi and 90Y) chelates of anti-Tac and with recombinant ‘humanized’ anti-Tac." @default.
• W2052606277 created "2016-06-24" @default.
• W2052606277 creator A5035996420 @default.
• W2052606277 date "1988-12-01" @default.
• W2052606277 modified "2023-10-14" @default.
• W2052606277 title "The multichain interleukin-2-receptor: A target for immunotherapy of patients with adult T-cell leukemia, autoimmune disorders and individuals receiving allografts" @default.
• W2052606277 cites W1480351756 @default.
• W2052606277 cites W1506177294 @default.
• W2052606277 cites W1508418323 @default.
• W2052606277 cites W1535854559 @default.
• W2052606277 cites W1539383686 @default.
• W2052606277 cites W1549764875 @default.
• W2052606277 cites W1560071173 @default.
• W2052606277 cites W1565589271 @default.
• W2052606277 cites W1569342091 @default.
• W2052606277 cites W1591641472 @default.
• W2052606277 cites W1651116050 @default.
• W2052606277 cites W1967112185 @default.
• W2052606277 cites W1986004077 @default.
• W2052606277 cites W1986876944 @default.
• W2052606277 cites W1986924748 @default.
• W2052606277 cites W1988368135 @default.
• W2052606277 cites W1989671244 @default.
• W2052606277 cites W1993686365 @default.
• W2052606277 cites W2012014689 @default.
• W2052606277 cites W2012939559 @default.
• W2052606277 cites W2019744876 @default.
• W2052606277 cites W2032151689 @default.
• W2052606277 cites W2051962533 @default.
• W2052606277 cites W2053734665 @default.
• W2052606277 cites W2053798662 @default.
• W2052606277 cites W2062482701 @default.
• W2052606277 cites W2065716796 @default.
• W2052606277 cites W2076979493 @default.
• W2052606277 cites W2077228061 @default.
• W2052606277 cites W2088621363 @default.
• W2052606277 cites W2102524411 @default.
• W2052606277 cites W2140270007 @default.
• W2052606277 cites W2145498103 @default.
• W2052606277 cites W2152922534 @default.
• W2052606277 cites W2155826396 @default.
• W2052606277 cites W2157953677 @default.
• W2052606277 cites W2171199256 @default.
• W2052606277 cites W2262549231 @default.
• W2052606277 cites W2320441301 @default.
• W2052606277 cites W2395185936 @default.
• W2052606277 cites W2413679075 @default.
• W2052606277 cites W44978258 @default.
• W2052606277 doi "https://doi.org/10.1016/0896-8411(88)90055-8" @default.
• W2052606277 hasPublicationYear "1988" @default.
• W2052606277 type Work @default.
• W2052606277 sameAs 2052606277 @default.
• W2052606277 citedByCount "6" @default.
• W2052606277 crossrefType "journal-article" @default.
• W2052606277 hasAuthorship W2052606277A5035996420 @default.
• W2052606277 hasConcept C147483822 @default.
• W2052606277 hasConcept C153911025 @default.
• W2052606277 hasConcept C157695867 @default.
• W2052606277 hasConcept C159654299 @default.
• W2052606277 hasConcept C170493617 @default.
• W2052606277 hasConcept C185592680 @default.
• W2052606277 hasConcept C197462201 @default.
• W2052606277 hasConcept C203014093 @default.
• W2052606277 hasConcept C2776090121 @default.
• W2052606277 hasConcept C2777371288 @default.
• W2052606277 hasConcept C2778453870 @default.
• W2052606277 hasConcept C2779281246 @default.
• W2052606277 hasConcept C49382859 @default.
• W2052606277 hasConcept C542903549 @default.
• W2052606277 hasConcept C55493867 @default.
• W2052606277 hasConcept C86803240 @default.
• W2052606277 hasConcept C8891405 @default.
• W2052606277 hasConcept C95444343 @default.
• W2052606277 hasConceptScore W2052606277C147483822 @default.
• W2052606277 hasConceptScore W2052606277C153911025 @default.
• W2052606277 hasConceptScore W2052606277C157695867 @default.
• W2052606277 hasConceptScore W2052606277C159654299 @default.
• W2052606277 hasConceptScore W2052606277C170493617 @default.
• W2052606277 hasConceptScore W2052606277C185592680 @default.
• W2052606277 hasConceptScore W2052606277C197462201 @default.
• W2052606277 hasConceptScore W2052606277C203014093 @default.
• W2052606277 hasConceptScore W2052606277C2776090121 @default.
• W2052606277 hasConceptScore W2052606277C2777371288 @default.
• W2052606277 hasConceptScore W2052606277C2778453870 @default.
• W2052606277 hasConceptScore W2052606277C2779281246 @default.
• W2052606277 hasConceptScore W2052606277C49382859 @default.
• W2052606277 hasConceptScore W2052606277C542903549 @default.
• W2052606277 hasConceptScore W2052606277C55493867 @default.
• W2052606277 hasConceptScore W2052606277C86803240 @default.
• W2052606277 hasConceptScore W2052606277C8891405 @default.
• W2052606277 hasConceptScore W2052606277C95444343 @default.
• W2052606277 hasIssue "6" @default.
• W2052606277 hasLocation W20526062771 @default.
• W2052606277 hasOpenAccess W2052606277 @default.
• W2052606277 hasPrimaryLocation W20526062771 @default.
• W2052606277 hasRelatedWork W1579828543 @default.
• W2052606277 hasRelatedWork W1595075646 @default.
• W2052606277 hasRelatedWork W1656467347 @default.

• next